Cross-Sector entity
pharma is the sole category represented across all 1 tracked stories. Bhavin Mehta is most often covered alongside Dr. Reddy's Laboratories, which appears in 1 of these 1 story. The tracked stories average 2 original sources each. Bhavin Mehta appears in 1 tracked Cross-Sector story from July 27, 2026.
1 verified story tracked
Last mentioned: Jul 27, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
pharma is the sole category represented across all 1 tracked stories. Bhavin Mehta is most often covered alongside Dr. Reddy's Laboratories, which appears in 1 of these 1 story. The tracked stories average 2 original sources each. Bhavin Mehta appears in 1 tracked Cross-Sector story from July 27, 2026.
Computed from the 1 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Bhavin Mehta. Shared-story counts are live from our verified record — not editorial picks.
The zero-tariff India-UK trade pact propels Indian pharmaceutical exports to a projected $981M, offering biotech and pharma firms expanded market access, lower costs, and new collaboration channels in R&D and manufacturing.
Source: indiagazette.com · britainnews.net
